Pancreatic Cancer, Research and Clinical Trials

Meet the investigator: Daniel D. Billadeau, Ph.D.

By Nicole Ferrara • December 11, 2019
Estimated reading time: 1 minute

At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Daniel D. Billadeau, Ph.D., an oncology researcher at Mayo Clinic in Rochester, Minnesota, talks about his work investigating pancreatic cancer. Dr. Billadeau is also a principal investigator of the Mayo Clinic Pancreatic Cancer SPORE.

Related

This article was originally published in Forefront, Mayo Clinic Cancer Center's online magazine, which ceased publication in December 2020.

cancer pancreatic cancer Pancreatic Cancer research Research and Clinical Trials SPORE
Subscribe
Request an Appointment
Find a Clinical Trial
Sorting out T-cell lymphoma

Dr. Andrew Feldman and his team are helping to redefine the classification of T-cell lymphomas, an often fatal group of immune system tumors.

Investigating dual CAR-T cell therapy for multiple myeloma

Dr. Reona Sakemura is researching treatment resistance mechanisms in multiple myeloma to make immunotherapy more effective.

Mayo Clinic researchers study rare genetic condition to tackle colorectal cancer

Researchers found the drug erlotinib reduced the number of polyps formed in the bowels of patients with Familial Adenomatous Polyposis (FAP).